STOCKS / Finance

Esperion And Medicines Co. Recover From Amgen-Induced Pitfall

From News - Investor's Business Daily
March 20, 2017 - 11:26am
Esperion stock recovered from an Amgen-induced pitfall on Monday after the biotech outlined its path to FDA approval for a cholesterol drug.


Continue reading this article »